Catalyst Wire Dossier Catalyst Wire Dossier

RD047-26

· Oculus Innovative Sciences, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RD047-26, covering 2012-05-30 to 2012-05-30. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults [Phase 2]

See pricing